Učitavanje...

Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives

Chagas disease is a chronic infection caused by the protozoan parasite Trypanosoma cruzi, manifested in progressive cardiomyopathy and/or gastrointestinal dysfunction. Therapeutic options to prevent or treat Chagas disease are limited. CYP51, the enzyme key to the biosynthesis of eukaryotic membrane...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vieira, Debora F., Choi, Jun Yong, Roush, William R., Podust, Larissa M.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091728/
https://ncbi.nlm.nih.gov/pubmed/24771705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cbic.201402027
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!